Clinical Trials
6 trialsNCT05244577 2023-02-06
Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer
Sun Yat-sen University
Phase 3 Unknown
NCT03571126 2021-07-13
Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer
Zunyi Medical College
Phase 4 Unknown
NCT04536558 2020-09-02
OFFER
Sun Yat-sen University
Phase 3 Unknown
NCT03679182 2018-09-20
Efficacy and Safety of Olanzapine for the Treatment of Nausea and Vomiting in Palliative Cancer Care
Khon Kaen University
Phase 2 Unknown
NCT03575637 2018-07-03
Olanzapine Improves the Chemotherapy Tolerance of Advanced Gastric Cancer
Peking University
Phase 2 Unknown
NCT02290470 2014-11-14
Olanzapine Against Delayed Nausea and Vomiting in Women Receiving Carboplatin Plus Paclitaxel
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase 2 Unknown